Clinical Trials Browser

OTHER_GOV × Breast × 90 days × Clear all

NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Phase NA Enrolling by invitation

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

Breast Neoplasms

NCT07464769 2026-03-11

KompXX

Phase NA Not yet recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT03877029 2026-03-09

Long-term Effects of Breast Cancer Treatment

Breast Neoplasms

NCT06704659 2026-03-09

RAY-no-BAN

Phase NA Recruiting

Breast Neoplasms, Recurrence

NCT07425379 2026-02-24

Prehabilitation in Breast Cancer Surgery

Phase NA Not yet recruiting

Breast Neoplasms

NCT06104371 2026-02-23

SentiNeo2

Breast Neoplasms

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07371702 2026-01-29

PERMS

Not yet recruiting

Breast Neoplasms

NCT07357207 2026-01-23

VIT-BC

Phase NA Enrolling by invitation

Female Breast Cancer Patients

NCT07338721 2026-01-15

Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?

Breast Neoplasms

NCT06032390 2026-01-14

AIMS Norway

Phase NA Recruiting

150,000 enrolled

Breast Neoplasms

NCT06967103 2026-01-08

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT07327021 2026-01-08

NOGA

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07301580 2025-12-24

Prehabilitation of Breast Cancer-Related Lymphedema

Phase NA Completed

Breast Cancer Lymphedema, Fatigue Syndrome, Chronic

NCT02698202 2025-12-19

Screening for Breast Cancer With Digital Breast Tomosynthesis

Phase NA Completed

26,877 enrolled

Breast Neoplasms